Viewing Study NCT01536392


Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2026-01-01 @ 9:01 PM
Study NCT ID: NCT01536392
Status: COMPLETED
Last Update Posted: 2021-06-11
First Post: 2012-02-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2011-1107
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View